Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF

Thrombosis and Haemostasis

Volumn 82, Issue 5, 1999, Pages 1382-1385

  Obert, Bernadette ^a   Tout, Hélène ^a   Veyradier, Agnès ^a   Fressinaud, Edith ^a   Meyer, Dominique ^a   Girma, Jean Pierre ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b Dept Environ Med Natl Inst Publ HIth   (Norway)

Author keywords

Monoclonal antibodies; Proteolysis measurement; Von Willebrand factor; vWF cleaving protease

Indexed keywords

MONOCLONAL ANTIBODY; PROTEINASE; VON WILLEBRAND FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032728603     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614779     Document Type: Article

References (21)

1. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand Factor. Cleavage is present in normal individuals, increased in type IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest 1986; 77: 947-51.
2. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990; 87: 6306-10.
3. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-34.
4. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
5. Tsai HM, Nagel RL, Hatcher VB, Sussman II. Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 1989; 73: 2074-6.
6. Moake JL, Chow TW. Thrombotic thrombocytopenic purpura: Understanding a disease no longer rare. Am J Med Sci 1998; 316: 105-19.
7. Tsai HM, Lian ECY. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
8. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
9. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocylopenic purpura. Blood 1997; 89: 3097-103.
10. Furlan M, Robles R, Solenthaler M, Lammle B. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombolic thrombocytopenic purpura. Blood 1998; 91: 2839-46.
11. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-5.
12. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
13. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type-IIA von Willebrand disease mutations. J Biol Chem 1992; 267: 4424-30.
14. Ribba AS, Voorberg J, Meyer D, Pannekoek H, Pietu G. Characterization of recombinant von Willebrand Factor corresponding to mutations in Type-IIA and Type-IIB von Willebrand disease. J Biol Chem 1992; 267: 23209-15.
15. Tsai HM, Sussman II, Ginsburg D, Lankhof H, Sixma JJ, Nagel RL. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: Inhibition by doxycycline and by monoclonal antibody VP-1. Blood 1997; 89: 1954-62.
16. van der Plas RM, Schiphorst ME, Huizinga EG, Hene RJ, Verdonck LF, Sixma JJ, Fijnheer R, von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999; 93: 3798-802.
17. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to Factor VIII. Blood 1989; 5: 1591-9.
18. Meyer D, Zimmerman TS, Obert B, Edgington TS. Hybridoma antibodies to human von Willebrand Factor. I. Characterization of seven clones. Br J Haematol 1984; 57: 597-608.
19. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6- tetrachloro-3a, 6a- diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
20. Obert B, Houllier A, Meyer D, Girma JP. Conformational changes in the A3 domain of von Willebrand Factor modulate the interaction of the A1 domain with platelet glycoprotein Ib. Blood 1999; 93: 1959-68.
21. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of Factor VIII/von Willebrand Factor. Blood 1981; 57: 1140-3.